Healthcare -
Biotechnology - NASDAQ - US
$ 30.75
-0.646 %
$ 13.7 B
Market Cap
12.11
P/E
RPRX - REVENUE
Revenue RPRX - Royalty Pharma plc
2.35 B
LAST VALUE
1.41%
2 YEAR CAGR
5.58%
5 YEAR CAGR
0.00%
10 YEAR CAGR